Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2007; 13(2): 228-235
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.228
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.228
Gene | Acc. No. | HepG2 | 2.2.15 | HepG2/lam | 2.2.15/lam |
I complete inhibition | |||||
MxA | M33882 | 5.9 | 0.6 | 4.0 | 0.8 |
cig5 | AF026941 | 2.2 | 0.9 | 2.1 | 1.2 |
II partial inhibition | |||||
IFITM3 | X57352 | 3.4 | 1.6 | 3.4 | 1.8 |
IFITM2 | X57351 | 2.7 | 1.6 | 2.2 | 1.8 |
III reversible inhibition | |||||
IFI 6-16 | BC015603 | 7.9 | 4.4 | 7.2 | 6.5 |
IFITM1 | M24594 | 4.9 | 2.5 | 4.8 | 4.6 |
IV no inhibition | |||||
2-5OAS | D00068 | 3.8 | 4.0 | 4.4 | 5.8 |
MxB | M30818 | 1.4 | 2.0 | 1.4 | 1.9 |
Caspase 7 | U67319 | 2.3 | 2.4 | 2.2 | 2.1 |
IFI 17 | J04164 | 3.3 | 2.9 | 2.8 | 2.7 |
IFI 27 | X67325 | 1.9 | 2.1 | 1.8 | 2.2 |
IFI T4 | U72882 | 2.7 | 1.9 | 2.6 | 1.8 |
RING4 | X57522 | 2.4 | 2.3 | 2.5 | 3.5 |
- Citation: Guan SH, Lu M, Grünewald P, Roggendorf M, Gerken G, Schlaak JF. Interferon-α response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroenterol 2007; 13(2): 228-235
- URL: https://www.wjgnet.com/1007-9327/full/v13/i2/228.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i2.228